menu
    • menu
    [{"orgOrder":0,"company":"BioGaia Pharma","sponsor":"Atlantia Food Clinical Trials | CTC Clinical Trial Consultants","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"SWEDEN","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Lactobacillus Reuteri","moa":"||Bacteria microbiome","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"BioGaia Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BioGaia Pharma \/ Atlantia Food Clinical Trials | CTC Clinical Trial Consultants","highestDevelopmentStatusID":"1","companyTruncated":"BioGaia Pharma \/ Atlantia Food Clinical Trials | CTC Clinical Trial Consultants"},{"orgOrder":0,"company":"BioGaia Pharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"SWEDEN","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Lactobacillus Reuteri","moa":"||Bacteria microbiome","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"BioGaia Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BioGaia Pharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"BioGaia Pharma \/ Inapplicable"},{"orgOrder":0,"company":"Northwest Health","sponsor":"Neolac Inc dba Medolac Laboratories","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"Northwest Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Northwest Health \/ Neolac Inc dba Medolac Laboratories","highestDevelopmentStatusID":"1","companyTruncated":"Northwest Health \/ Neolac Inc dba Medolac Laboratories"},{"orgOrder":0,"company":"Meiji Seika Pharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"JAPAN","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Human Milk Oligosaccharide","moa":"||Undisclosed","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"Meiji Seika Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Meiji Seika Pharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Meiji Seika Pharma \/ Inapplicable"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"HMO","moa":"||Undisclosed","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nestle Health Sciences SA \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Inapplicable"},{"orgOrder":0,"company":"NovoNatum Ltd","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Lactobacillus Reuteri","moa":"||Bacteria microbiome","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"NovoNatum Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NovoNatum Ltd \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"NovoNatum Ltd \/ Inapplicable"},{"orgOrder":0,"company":"Astel Medica","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Bactecal D","moa":"||Undisclosed","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"Astel Medica","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Astel Medica \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Astel Medica \/ Inapplicable"},{"orgOrder":0,"company":"Archer Daniels Midland","sponsor":"Atlantia Food Clinical Trials | Vedic Lifesciences Pvt. Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"U.S.A","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Immune","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"Archer Daniels Midland","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Sachet","sponsorNew":"Archer Daniels Midland \/ Atlantia Food Clinical Trials | Vedic Lifesciences Pvt. Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Archer Daniels Midland \/ Atlantia Food Clinical Trials | Vedic Lifesciences Pvt. Ltd."},{"orgOrder":0,"company":"Evolve BioSystems, Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"B. Infantis EVC001","moa":"||Undisclosed","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"Evolve BioSystems, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Evolve BioSystems, Inc. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Evolve BioSystems, Inc. \/ Inapplicable"},{"orgOrder":0,"company":"AB Biotics","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Ab-Kolicare","moa":"||Undisclosed","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"AB Biotics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"AB Biotics \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"AB Biotics \/ Inapplicable"},{"orgOrder":0,"company":"CHRISTUS Health","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Pediatrics","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2024","type":"Inapplicable","leadProduct":"Ferrous Sulfate","moa":"||Iron stores","graph1":"Pediatrics","graph2":"Undisclosed","graph3":"CHRISTUS Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"CHRISTUS Health \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"CHRISTUS Health \/ Inapplicable"}]

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            CHRISTUS Health

                            Country arrow
                            EPSC
                            Not Confirmed

                            CHRISTUS Health

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ferrous Sulfate,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            August 15, 2024

                            Lead Product(s) : Ferrous Sulfate,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            BioGaia Pharma

                            Country arrow
                            EPSC
                            Not Confirmed

                            BioGaia Pharma

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactobacillus Reuteri,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            June 17, 2024

                            Lead Product(s) : Lactobacillus Reuteri,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Nestle Health Sciences SA

                            Switzerland arrow
                            EPSC
                            Not Confirmed

                            Nestle Health Sciences SA

                            Switzerland arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HMO,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Human Milk Oligosaccharide (HMO) Supplementation in Colic Management

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            September 26, 2022

                            Lead Product(s) : HMO,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            BioGaia Pharma

                            Country arrow
                            EPSC
                            Not Confirmed

                            BioGaia Pharma

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactobacillus Reuteri,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Atlantia Food Clinical Trials | CTC Clinical Trial Consultants

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            August 23, 2022

                            Lead Product(s) : Lactobacillus Reuteri,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Atlantia Food Clinical Trials | CTC Clinical Trial Consultants

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Archer Daniels Midland

                            U.S.A arrow
                            EPSC
                            Not Confirmed

                            Archer Daniels Midland

                            U.S.A arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probiotic,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Atlantia Food Clinical Trials | Vedic Lifesciences Pvt. Ltd.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            June 27, 2022

                            Lead Product(s) : Probiotic,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Atlantia Food Clinical Trials | Vedic Lifesciences Pvt. Ltd.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            AB Biotics

                            Country arrow
                            EPSC
                            Not Confirmed

                            AB Biotics

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ab-Kolicare,Lactobacillus reuteri DSM17938

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prospective Study to Determine the Factors Influencing Infant Colic

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            March 09, 2022

                            Lead Product(s) : Ab-Kolicare,Lactobacillus reuteri DSM17938

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Meiji Seika Pharma

                            Japan arrow
                            EPSC
                            Not Confirmed

                            Meiji Seika Pharma

                            Japan arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Human Milk Oligosaccharide,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Influence by Dietary Human Milk Oligosaccharide in Low Birth Weight Infants

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            January 24, 2022

                            Lead Product(s) : Human Milk Oligosaccharide,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Evolve BioSystems, Inc.

                            Country arrow
                            EPSC
                            Not Confirmed

                            Evolve BioSystems, Inc.

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : B. Infantis EVC001,Lactose

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The COLIC Study: Colonization of the Infant Gut With B. Infantis EVC001 to Reduce Symptoms of Colic

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            November 22, 2021

                            Lead Product(s) : B. Infantis EVC001,Lactose

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Astel Medica

                            Country arrow
                            EPSC
                            Not Confirmed

                            Astel Medica

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Bactecal D,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            September 22, 2021

                            Lead Product(s) : Bactecal D,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            Northwest Health

                            Country arrow
                            EPSC
                            Not Confirmed

                            Northwest Health

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Medolac Human Milk Based Human Milk Fortifier,Inapplicable

                            Therapeutic Area : Pediatrics

                            Study Phase : Undisclosed

                            Sponsor : Neolac Inc dba Medolac Laboratories

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Novel Human Milk Based Human Milk Fortifier

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 20, 2020

                            Lead Product(s) : Medolac Human Milk Based Human Milk Fortifier,Inapplicable

                            Therapeutic Area : Pediatrics

                            Highest Development Status : Undisclosed

                            Sponsor : Neolac Inc dba Medolac Laboratories

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth